• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Akums Drugs & Pharmaceuticals Ltd.
    07 Feb 2025
    454.25
    -2.92%
    Akums Drugs and Pharma Q3 Results: Adjusted Profit Rises 15% To Rs 66.3 Crore
    Akums Drugs and Pharma Q3 Results: Adjusted Profit Rises 15% To Rs 66.3 Crore
    NDTV Profit
    Adjusted profit is calculated as the profit for the quarter/period plus fair value changes to financial instruments less tax impact on account of business merger, the filing said.
    Copy LinkShare onShare on Share on Share on
    ICICI Securities Limited decreased Buy price target of Akums Drugs & Pharmaceuticals Ltd. to 655.0 on 11 Aug, 2025.
    Akums Drugs slips 3% after posting 66% decline in Q3 profits, rev down 7%
    Business Standard | 07 Feb 2025
    logo
    Wockhardt Ltd.
    07 Feb 2025
    1427.50
    0.08%
    Wockhardt Q3 Results: Pharma Major Swings Back To Profit As Expenses Fall
    Wockhardt Q3 Results: Pharma Major Swings Back To Profit As Expenses Fall
    NDTV Profit
    On the operating side, Ebitda jumped 84.6% to Rs 96 crore, while margin expanded to 13.3% from 7.4%.
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 2.60% of shares in last quarter. Total pledge stands at 15.64% of promoter holdings
    logo
    Cipla Ltd.
    07 Feb 2025
    1589.40
    0.58%
    Cipla stock shows strength on charts, adopt Bull Spread: Nandish Shah
    Business Standard
    Cipla share price: The short-term trend turned positive as Cipla stock price closed above its 5 and 11 day EMA
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1713.00 from 9 brokers.
    logo
    Aurobindo Pharma Ltd.
    06 Feb 2025
    1027.90
    0.16%
    Aurobindo Pharma Q3FY25 results: PAT falls 10% to Rs 845.56 crore
    Business Standard
    Company board approves purchase of 80 per cent share in step-down subsidiary Tergene Biotech
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has lost -34.24% in the last 1 Year
    Aurobindo Pharma Q3 Results: Profit Falls 9.7%, Misses Estimates
    NDTV Profit | 06 Feb 2025
    logo
    Emcure Pharmaceuticals Ltd.
    06 Feb 2025
    1393.40
    -2.68%
    Emcure Pharmaceuticals Q3FY25: Profit grows 35.4%, revenue soars 17.6%
    Business Standard
    Sequentially, the revenue from operations fell by 1.9 per cent, with net profit also falling by 20.9 per cent
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd.'s price crossed below 30Day SMA today
    logo
    AstraZeneca Pharma India Ltd.
    06 Feb 2025
    8460.50
    1.58%
    AstraZeneca reports better than expected profit on higher cancer drug sales
    Business Standard
    Earnings per share excluding some items surged to $2.09, Astra said Thursday, higher than the $2.04 estimated by analysts surveyed by Bloomberg
    Copy LinkShare onShare on Share on Share on
    Number of MF schemes increased from 53 to 60 in Jun 2025 qtr.
    logo
    Dr. Reddy's Laboratories Ltd.
    06 Feb 2025
    1260.10
    0.02%
    Dr Reddy's Unit Ties Up With Shanghai Henlius Biotech
    Dr Reddy's Unit Ties Up With Shanghai Henlius Biotech
    NDTV Profit
    As part of the tie-up, Henlius will be responsible for development, manufacturing and commercial supply, and may receive up to a total of $131.6 million.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.
    logo
    Abbott India Ltd.
    06 Feb 2025
    31480.00
    0.02%
    Abbott India gains 10% in 2 days after posting healthy Q3 show; Details
    Business Standard
    The company's Q3 profit increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore
    Copy LinkShare onShare on Share on Share on
    Abbott India Ltd. is trading below its 30 day SMA of 33222.8
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    06 Feb 2025
    1724.30
    1.05%
    JB Chemicals Q3 Review Domestic Biz, CMO To Drive Growth; Nirmal Bang Hikes Target Price, Maintains 'Buy'
    JB Chemicals Q3 Review Domestic Biz, CMO To Drive Growth; Nirmal Bang Hikes Target Price, Maintains 'Buy'
    NDTV Profit
    JB Chemicals remains Nirmal Bang's top pharma pick, supported by strong domestic and CDMO growth, high return ratios, and a lean balance sheet.
    Copy LinkShare onShare on Share on Share on
    J B Chemicals & Pharmaceuticals Ltd. is trading above all available SMAs
    JB Chemicals Q3 PAT rises 21 pc to 162 cr
    livemint | 06 Feb 2025
    logo
    Lupin Ltd.
    05 Feb 2025
    1894.90
    -0.39%
    Lupin surges 8% in 2 days on USFDA nod for generic HIC drug
    Business Standard
    The drugs include Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets and the company is the exclusive first-to-file for this products
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd